2 Minute Medicine Rewind July 30, 2023
Efficacy and Safety of Recombinant Human Prourokinase in the Treatment of Acute Ischemic Stroke Within 4.5 Hours of Stroke Onset:...
Efficacy and Safety of Recombinant Human Prourokinase in the Treatment of Acute Ischemic Stroke Within 4.5 Hours of Stroke Onset:...
1. In this single-centre prospective cohort study, development of a Swedish Palliative Care Guide to improve integrated geriatric and palliative...
1. In a Swedish cohort, lower cardiorespiratory fitness (CRF) as measured by maximal oxygen consumption (Vo2max) was found to be...
1. In this prospective cohort study, it was found that the lateral ventricles, front and temporal lobes, and anterior and...
1. This prespecified secondary analysis of data from a randomized clinical trial (RCT) identified a potential cognitive subtype (or “biotype”)...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.